Last updated 2026-08-22
- Raised $1.2M Seed round
Total raised
$1.2M
Stage
—
Founded
2020
Headcount
—
HQ
Jerusalem, Israel
Sector
Biomed
Website ↗Registrar ID: 516127750 (3BiotiX Pharma Ltd.)
About
3BiotiX is an emerging startup company specializing in innovative biofilm solutions. Its research focuses on antimicrobial medicinal treatments aimed at eliminating fungal and bacterial infections resistant to conventional treatments. The company is pioneering novel combination therapies to overcome infectious diseases by disarming stubborn biofilms that cause recurrence and refractory symptoms. 3BiotiX's current project focuses on transforming treatment for recurrent vulvovaginal candidiasis (RVVC).
Funding history · 1 round · $1.2M total
1 event/round · $1.2M Total Funding: $1.2M in Private Equity
Date unknown
Offices
Jerusalem, Israel · HQ / main office
Q&A
- What is 3BiotiX Pharma Ltd.'s primary focus?
- 3BiotiX Pharma Ltd. specializes in innovative biofilm solutions, developing antimicrobial medicinal treatments to eliminate fungal and bacterial infections resistant to conventional treatments.
- When was 3BiotiX Pharma Ltd. founded?
- 3BiotiX Pharma Ltd. was founded in 2020.
- What is the total amount of funding 3BiotiX Pharma Ltd. has raised?
- 3BiotiX Pharma Ltd. has raised a total of $1,200,000 in funding.
- What type of funding round has 3BiotiX Pharma Ltd. completed?
- 3BiotiX Pharma Ltd. has completed a Seed funding round, raising $1,200,000.
- Who are the co-founders of 3BiotiX Pharma Ltd.?
- The co-founders of 3BiotiX Pharma Ltd. are Alon Barzilay, Doron Steinberg, Amir Bassan, and Moshe Blumenkrantz.
- Who is the CEO of 3BiotiX Pharma Ltd.?
- Herve Nakache serves as the CEO of 3BiotiX Pharma Ltd.
- What is 3BiotiX Pharma Ltd.'s current project focus?
- 3BiotiX Pharma Ltd.'s current project focuses on transforming treatment for recurrent vulvovaginal candidiasis (RVVC).
- What is the core technology of 3BiotiX Pharma Ltd.?
- 3BiotiX Pharma Ltd.'s core technology is a proprietary formulation combining the antibiofilm effect of cannabidiol and the antifungal activity of an azole derivate.
Sectors & technology
Primary sector
Biomed
Technologies
Target customers
Business model
B2B
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | 3biotix.com |
|---|
Identifiers & details
| Founded | 2020 |
|---|
Radar intelligence
Web history (Wayback)
| Domain | 3biotix.com |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516127750 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2020-01-02 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 1 — violation (1) |
| Registered address | עין כרם 1 ירושלים |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-25 | עדכון הפרה |